Cachet Pharmaceutical Co Ltd
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical devices. It sells its products through online and offline channels. The company was founded in 1997 and is headquartered in Beijing, China.
Cachet Pharmaceutical Co Ltd (002462) - Total Liabilities
Latest total liabilities as of September 2025: CN¥6.59 Billion CNY
Based on the latest financial reports, Cachet Pharmaceutical Co Ltd (002462) has total liabilities worth CN¥6.59 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cachet Pharmaceutical Co Ltd - Total Liabilities Trend (2007–2024)
This chart illustrates how Cachet Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cachet Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Cachet Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Surgical Science Sweden AB (publ)
PINK:SUSRF
|
USA | $403.58 Million |
|
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
|
USA | $129.29 Million |
|
Huayi Compressor Co Ltd
SHE:000404
|
China | CN¥9.52 Billion |
|
Beijing Bewinner Communications Co Ltd
SHE:002148
|
China | CN¥181.57 Million |
|
Property For Industry Ltd.
PINK:PYIYF
|
USA | $762.59 Million |
|
Tanac Automation Co Ltd
SHE:300461
|
China | CN¥409.56 Million |
|
Nel ASA
PINK:NLLSY
|
USA | $1.08 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down Cachet Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cachet Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cachet Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual total liabilities of Cachet Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥7.97 Billion | -27.71% |
| 2023-12-31 | CN¥11.03 Billion | +3.71% |
| 2022-12-31 | CN¥10.64 Billion | +14.59% |
| 2021-12-31 | CN¥9.28 Billion | +5.35% |
| 2020-12-31 | CN¥8.81 Billion | +8.57% |
| 2019-12-31 | CN¥8.11 Billion | +14.01% |
| 2018-12-31 | CN¥7.12 Billion | +18.48% |
| 2017-12-31 | CN¥6.01 Billion | +35.17% |
| 2016-12-31 | CN¥4.44 Billion | +20.61% |
| 2015-12-31 | CN¥3.68 Billion | +28.27% |
| 2014-12-31 | CN¥2.87 Billion | +93.45% |
| 2013-12-31 | CN¥1.48 Billion | +87.45% |
| 2012-12-31 | CN¥792.20 Million | +62.19% |
| 2011-12-31 | CN¥488.45 Million | +21.36% |
| 2010-12-31 | CN¥402.48 Million | +13.90% |
| 2009-12-31 | CN¥353.36 Million | +36.36% |
| 2008-12-31 | CN¥259.14 Million | -7.81% |
| 2007-12-31 | CN¥281.09 Million | -- |